Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference


Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to announce that Doug Drysdale, Cybin's Chief Executive Officer, will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference, taking place April 16-17, 2024 in Toronto, Ontario.

Mr. Drysdale's presentation will be webcast live on Tuesday, April 16, 2024, at 1:30 p.m. ET. To listen to the event, please click here to access the webcast. The archived webcast will also be available on the Company's investor relations website on the Events & Presentations page.

About Cybin

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.

Cybin's goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The Company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.

Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.cybin.com or follow the team on X, LinkedIn, YouTube and Instagram.


These press releases may also interest you

at 18:02
AHRC Nassau's 75th Anniversary Spotlights History of Advocacy, Importance of Membership
The story of AHRC Nassau is one of love and relentless advocacy by parent advocates seeking to create a better world for their children with intellectual and developmental disabilities (I/DD). From a small support group of a dozen parents came a...

at 18:00
Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
Nektar Therapeutics will announce its financial results for the first quarter 2024 on Thursday, May 9, 2024, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review...

at 17:41
CYNTHIA DELGADO AND NEIL POWE NAMED TO TIME100 HEALTH LIST FOR FIGHTING KIDNEY TRANSPLANT BIAS
TIME has included the co-chairs of the National Kidney Foundation (NKF)/ American Society of Nephrology (ASN) Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases, among its first-ever list of the 100 most influential people...

at 17:33
Cheung Aesthetics & Wellness Introduces Cutting-Edge Technology to Reverse Aging Without Pain or Downtime
Cheung Aesthetics & Wellness, a leading Chicago dermatology practice, is among the first to offer groundbreaking technology that reverses facial aging and reduces wrinkles without discomfort, needles, or downtime. The clinic is hosting "Spring...

at 17:31
Global Angioplasty Balloons and Stents Market to Exhibit Substantial Growth at a CAGR of ~4% by 2030 | DelveInsight
The surge in demand for angioplasty balloons and stents is mainly driven by the increasing prevalence of cardiovascular diseases (CVDs), the growing preference for minimally invasive procedures, and advancements in drug-coated/drug-eluting balloon...

at 17:29
Great-West Lifeco announces election of Directors
Great-West Lifeco today announced that, at its Annual Meeting of Shareholders, all of the 19 director nominees listed in its Management Proxy Circular dated March 7, 2024 were elected. The detailed results of the vote for the election of directors...

More news about Health...


News published on and distributed by: